Neo Ivy Capital Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-20,306
| Closed | -$1.36M | – | 307 |
|
|
2024
Q3 | $1.36M | Sell |
20,306
-5,354
| -21% | -$359K | 0.44% | 98 |
|
|
2024
Q2 | $2.91M | Buy |
+25,660
| New | +$2.91M | 0.57% | 82 |
|
|
2022
Q4 | $291K | Buy |
+2,568
| New | +$291K | 0.2% | 195 |
|
|
2021
Q2 | – | Sell |
-484
| Closed | -$43K | – | 492 |
|
|
2021
Q1 | $43K | Buy |
+484
| New | +$43K | 0.05% | 341 |
|
|
2020
Q4 | – | Sell |
-2,172
| Closed | -$223K | – | 460 |
|
|
2020
Q3 | $223K | Buy |
+2,172
| New | +$223K | 0.23% | 176 |
|
|
2020
Q2 | – | Sell |
-332
| Closed | -$22K | – | 495 |
|
|
2020
Q1 | $22K | Buy |
+332
| New | +$22K | 0.04% | 372 |
|
|
2019
Q4 | – | Sell |
-1,256
| Closed | -$54K | – | 294 |
|
|
2019
Q3 | $54K | Buy |
+1,256
| New | +$54K | 0.04% | 245 |
|
|
2019
Q2 | – | Sell |
-18,560
| Closed | -$552K | – | 305 |
|
|
2019
Q1 | $552K | Buy |
+18,560
| New | +$552K | 0.31% | 144 |
|